From: Trabecular bone scores in young HIV-infected men: a matched case-control study
a. Correlations between BMD and TBS in patients with HIV and matched controls | ||||||||
Group | BMD, g/cm2 | |||||||
Lumbar spine | Femoral neck | Total hip | ||||||
Control | ||||||||
TBS, L1–L4 | 0.449 (< 0.001) | 0.393 (< 0.001) | 0.446 (< 0.001) | |||||
HIV | ||||||||
TBS, L1–L4 | 0.368 (0.001) | 0.384 (< 0.001) | 0.401 (< 0.001) | |||||
b. Correlations between clinical data and TBS in patients with HIV | ||||||||
Group | BMI, kg/m2 | 25[OH]vitamin D | C-peptide | Osteocalcin | Duration after HIV diagnosis | Nadir CD4 count | Duration of ART | Durationa of tenofovir exposure |
TBS, L1–L4 | 0.112 (0.321) | 0.184 (0.107) | −0.008 (0.946) | −0.088 (0.449) | −0.202 (0.07) | 0.031 (0.399) | −0.07 (0.538) | − 0.326 (0.04) |